Please sign in to follow a disease.
Idiopathic aplastic anemia
MONDO:0012197Aplastic anemia without a known cause.
Also known as: idiopathic aplastic aplasia, idiopathic bone marrow failure, anaemia aplastic, anemia aplastic, aplastic Anemia, susceptibility to, aplastic anaemia, aplastic anaemia idiopathic, aplastic anemia
18 clinical trials for this condition and its sub-types, 9 tagged with Idiopathic aplastic anemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for older adults with rare blood disorder: safer transplant regimen under study
Disease control Recruiting nowThis study tests a new combination of drugs (busulfan, fludarabine, cyclophosphamide, and r-ATG) as preparation for a stem cell transplant in people aged 40-60 with severe aplastic anemia. The goal is to see if this regimen helps the transplant succeed with fewer failures. The st…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New stem cell protocol offers hope for older adults with aplastic anemia
Disease control Recruiting nowThis study tests a stem cell transplant method for adults aged 40 to 60 with severe aplastic anemia that has not improved or has returned after standard drug therapy. The approach uses a special drug after transplant to lower the risk of graft-versus-host disease, a common and se…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Double stem cell transplant could be Game-Changer for rare blood disorder
Disease control Recruiting nowThis study tests whether adding umbilical cord blood to a half-matched stem cell transplant can help people with aplastic anemia, a serious condition where the bone marrow stops making enough blood cells. About 224 participants aged 14 and older will receive either the combined t…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to tame harsh side effects of aplastic anemia therapy
Knowledge-focused Recruiting nowThis study watches 200 people with aplastic anemia who are getting ATG/ALG treatment for the first time. Researchers will track side effects like serum sickness, organ damage, and infusion reactions to learn how common and severe they are. The goal is to create better guidelines …
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC